This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AXP BMY DO JPM STJ


American Express
(AXP - Get Report) was upgraded at Morgan Stanley to overweight. Twelve-month price target is $100. OptBlue should drive growth, and the company should see strong spending volume, Morgan Stanley said.

Bristol-Myers (BMY) was upgraded at BMO Capital to outperform from market perform. Twelve-month price target is $60. Immuno-oncology pipeline should drive growth in the coming quarters, BMO Capital said.

Bristow (BRS) was upgraded at William Blair to outperform from market perform. Valuation call, William Blair said.

Cinemark (CNK) was upgraded at J.P. Morgan to overweight from neutral. Stock has overreacted to the company's Latin America exposure, J.P. Morgan said.

Commvault (CVLT) was upgraded to outperform from market perform, JMP Securities said. Twelve-month price target is $80. Survey suggests that customers will spend more this year, JMP Securities said.

Must Read: Analysts' Actions: CHRW CMI IRBT K SBUX

Diamond Offshore (DO) was upgraded at FBR Capital Markets to market perform from underperform. Valuation call, based on a 12-month price target of $45, FBR Capital Markets said.

FMC Technologies (FTI) was downgraded at William Blair to market perform from outperform. Company lacks near-term catalysts, William Blair said.

Synageva (GEVA) was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $110. Sebelipase alfa should be the company's next big catalyst, J.P. Morgan said.

Ingram Micro (IM) was upgraded at Brean Capital to buy from hold. Twelve-month price target is $31. Demand is stabilizing and the company is restoring profitability in key regions, Brean Capital said.

JPMorgan Chase (JPM - Get Report) was upgraded at Societe Generale to buy from hold. Twelve-month price target is $66. Company will likely settle mortgage litigation, and the loan growth outlook is improving, Societe Generale said.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JPM $62.08 -0.77%
AXP $64.54 -0.48%
FB $117.60 0.14%
GOOG $694.81 0.35%
TSLA $232.01 -0.13%


Chart of I:DJI
DOW 17,724.51 -26.40 -0.15%
S&P 500 2,056.47 -6.90 -0.33%
NASDAQ 4,749.7220 -13.5020 -0.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs